Polar Asset Management Partners’s Aspire Biopharma Holdings, Inc. Warrant ASBPW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.23K | Hold |
138,536
| – | – | ﹤0.01% | 548 |
|
2025
Q1 | $10.1K | Hold |
138,536
| – | – | ﹤0.01% | 444 |
|
2024
Q4 | $6.58K | Hold |
138,536
| – | – | ﹤0.01% | 602 |
|
2024
Q3 | $5.86K | Hold |
138,536
| – | – | ﹤0.01% | 658 |
|
2024
Q2 | $6.22K | Hold |
138,536
| – | – | ﹤0.01% | 639 |
|
2024
Q1 | $4.17K | Hold |
138,536
| – | – | ﹤0.01% | 732 |
|
2023
Q4 | $8.31K | Hold |
138,536
| – | – | ﹤0.01% | 669 |
|
2023
Q3 | $7.02K | Hold |
138,536
| – | – | ﹤0.01% | 795 |
|
2023
Q2 | $6.94K | Hold |
138,536
| – | – | ﹤0.01% | 883 |
|
2023
Q1 | $5.79K | Hold |
138,536
| – | – | ﹤0.01% | 962 |
|
2022
Q4 | $11.1K | Hold |
138,536
| – | – | ﹤0.01% | 1005 |
|
2022
Q3 | $15K | Hold |
138,536
| – | – | ﹤0.01% | 1148 |
|
2022
Q2 | $24K | Buy |
+138,536
| New | +$24K | ﹤0.01% | 1114 |
|